Anti-IRE1 antibody [9F2]
4
(6 Reviews)
|
(14 Publications)
Mouse Monoclonal IRE1 antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 14 publications. Immunogen corresponding to Recombinant Fragment Protein within Human ERN1 aa 250-450.
View Alternative Names
IRE1, ERN1, Serine/threonine-protein kinase/endoribonuclease IRE1, Endoplasmic reticulum-to-nucleus signaling 1, Inositol-requiring protein 1, Ire1-alpha, hIRE1p, IRE1a
- Flow Cyt
Unknown
Flow Cytometry - Anti-IRE1 antibody [9F2] (AB96481)
Overlay histogram showing Raji cells stained with ab96481 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab96481, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in Raji cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IRE1 antibody [9F2] (AB96481)
Immunohistochemical analysis of paraffin-embedded Human brain tissue (A) and stomach tissue (B), showing cytoplasmic localization using ab96481 at 1/200 dilution with DAB staining.
- WB
Unknown
Western blot - Anti-IRE1 antibody [9F2] (AB96481)
All lanes:
Western blot - Anti-IRE1 antibody [9F2] (ab96481) at 1/500 dilution
Lane 1:
Raji cell lysate
Lane 2:
A431 cell lysate
Lane 3:
Jurkat cell lysate
Lane 4:
HeLa cell lysate
Lane 5:
HEK293 cell lysate
Predicted band size: 110 kDa
false
- WB
CiteAb
Western blot - Anti-IRE1 antibody [9F2] (AB96481)
Western Blotting using Anti-IRE1 antibody [9F2], ab96481. Publication image from Jeon, Y. J. et al., 2018, Nat Commun, 30504895. Legend direct from paper.
TUSC3 deficiency selectively modulates Unfolded Protein Responses. a GSEA plots showing upregulation of the genes involved in Unfolded Protein Reponses. b Western blot analyses showing weakened IRE1α-XBP1 and PERK-EIF2α pathways in A549 TUSC3 KO cells whereas enhanced in TUSC3/HRD1 DKO cells in response to ER stress induction. c Subcellular fractionation assay showing enhanced chromatin-bound ATF6α in A549 TUSC3 KO and HRD1/TUSC3 DKO cells. The indicated cells were stimulated by 1.0 uM of TG for 6 or 9 h, respectively. Anti-Calnexin or anti-PARP1 antibody was used for ER/Golgi or Nuclear fraction markers, respectively. d Increased ATF6α-dependent ER heat-shock proteins in TUSC3 deficient cells. The cells were transfected by scrambled or siATF6α siRNAs for 48 h followed by exposing to DMSO or TM (3 ug/ml, 16 h). Western blot analysis shows elevated expression of GRP78 and GRP94 in A549 TUSC3 KO cells. A mitochondrial heat-shock protein, GRP75 was used for negative control. e Schematic diagram showing primary structure of TUSC3 protein and its mutants (TUSC3 CCSS). CSVC indicates the amino acids in C-X-X-C motif. f Rescued IRE1α and PERK expression by reconstitution of TUSC3 or its CCSS mutant. g Restored nuclear localization of the ATF6α protein by the reconstitution of TUSC3 but not by CCSS mutant in A549 TUSC3 KO cells. h Rescued the colonization ability of H460 TUSC3KO cells by suppressing ATF6α expression. 1 x 106 of the control cells or ATF6α knock-downed TUSC3 KO ells was intravenously injected into four NOD scid gamma mice. p-value was calculated by unpaired student t-test (*p = 0.002). The data for the tumor area from the control cells-injected mice are shared with Fig. 5g. i Co-expression analysis of ATF6α with TUSC3 protein showing inverse correlation between TUSC3 and ATF6α activation in lung cancer patient samples. p-value was obtained by Chi square analysis. The scale bar is shown as 150 µm. j Rescued colonization ability of TUSC3/HRD1 DKO cells. The tumor area was calculated as the total area of lung occupied by cancer is field of view using Image J software. The region for the cancer was expressed as percentage. p-value was calculated by unpaired student t-test (*p < 0.001)
false
- WB
CiteAb
Western blot - Anti-IRE1 antibody [9F2] (AB96481)
Western Blotting using Anti-IRE1 antibody [9F2], ab96481. Publication image from Jeon, Y. J. et al., 2018, Nat Commun, 30504895. Legend direct from paper.
TUSC3 deficiency selectively modulates Unfolded Protein Responses. a GSEA plots showing upregulation of the genes involved in Unfolded Protein Reponses. b Western blot analyses showing weakened IRE1α-XBP1 and PERK-EIF2α pathways in A549 TUSC3 KO cells whereas enhanced in TUSC3/HRD1 DKO cells in response to ER stress induction. c Subcellular fractionation assay showing enhanced chromatin-bound ATF6α in A549 TUSC3 KO and HRD1/TUSC3 DKO cells. The indicated cells were stimulated by 1.0 uM of TG for 6 or 9 h, respectively. Anti-Calnexin or anti-PARP1 antibody was used for ER/Golgi or Nuclear fraction markers, respectively. d Increased ATF6α-dependent ER heat-shock proteins in TUSC3 deficient cells. The cells were transfected by scrambled or siATF6α siRNAs for 48 h followed by exposing to DMSO or TM (3 ug/ml, 16 h). Western blot analysis shows elevated expression of GRP78 and GRP94 in A549 TUSC3 KO cells. A mitochondrial heat-shock protein, GRP75 was used for negative control. e Schematic diagram showing primary structure of TUSC3 protein and its mutants (TUSC3 CCSS). CSVC indicates the amino acids in C-X-X-C motif. f Rescued IRE1α and PERK expression by reconstitution of TUSC3 or its CCSS mutant. g Restored nuclear localization of the ATF6α protein by the reconstitution of TUSC3 but not by CCSS mutant in A549 TUSC3 KO cells. h Rescued the colonization ability of H460 TUSC3KO cells by suppressing ATF6α expression. 1 x 106 of the control cells or ATF6α knock-downed TUSC3 KO ells was intravenously injected into four NOD scid gamma mice. p-value was calculated by unpaired student t-test (*p = 0.002). The data for the tumor area from the control cells-injected mice are shared with Fig. 5g. i Co-expression analysis of ATF6α with TUSC3 protein showing inverse correlation between TUSC3 and ATF6α activation in lung cancer patient samples. p-value was obtained by Chi square analysis. The scale bar is shown as 150 µm. j Rescued colonization ability of TUSC3/HRD1 DKO cells. The tumor area was calculated as the total area of lung occupied by cancer is field of view using Image J software. The region for the cancer was expressed as percentage. p-value was calculated by unpaired student t-test (*p < 0.001)
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IRE1 is an important regulator in the unfolded protein response (UPR) a cellular reaction to stress in the ER. It operates as part of a complex mechanism facilitating the splicing of X-box binding protein 1 (XBP1) mRNA which results in the production of a potent transcription factor. IRE1 activity helps in restoring normal function of the cell by upregulating genes involved in protein folding secretion and degradation. Its actions are important for maintaining cellular homeostasis during stressful conditions.
Pathways
IRE1 is an integral component of the UPR pathway which works to alleviate ER stress. It interacts closely with other UPR transducers such as activating transcription factor 6 (ATF6) and protein kinase RNA-like ER kinase (PERK). IRE1 connects with the XBP1 pathway facilitating adaptive responses that enhance protein-folding capacity lipid biosynthesis and ER-associated degradation. Altogether these pathways mediate cell survival or apoptosis depending on the severity of the stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Cancer drug resistance (Alhambra, Calif.) 8:41 PubMed40843354
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 17: PubMed40507377
2025
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells international 2025:5091529 PubMed40476182
2025
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 8:366 PubMed37743418
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:1476 PubMed34765017
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 13: PubMed34638414
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 11:2936 PubMed32522993
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology international 44:488-498 PubMed31631456
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 9:5110 PubMed30504895
2018
Applications
Unspecified application
Species
Unspecified reactive species
Hepatology (Baltimore, Md.) 68:533-546 PubMed29506314
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com